BioSpace News Archive

On Thursday, December 6, House and Senate lawmakers released bipartisan draft legislation, known as the Verifying Accurate, Leading-edge In Vitro Clinical Test Development (VALID) Act, which outlines a framework for the Food and Drug Administration (FDA) to regulate laboratory developed tests.

Compelling documentary about the soaring price of medicines in the U.S. features interviews with academics, patients, advocates and political leaders, including Senator Bernie Sanders and Congressman Elijah Cummings and is narrated by Academy Award® Winner J.K. Simmons

New buy and build investment in leading healthcare governance, risk and compliance SaaS platform

Navidea Biopharmaceuticals, Inc. today announced that on November 23, 2018 the U.S. Food and Drug Administration (“FDA”) released a letter to the U.S. Patent and Trademark Office (“USPTO”) indicating that the USPTO is allowed to extend the patent duration of U.S. patent 6,409,990 for an additional 5 years or until May 12, 2025.

Magellan Health, Inc. (NASDAQ: MGLN) announced today its full year 2019 guidance parameters.

MassRoots, Inc. is pleased to announce that MassRoots has acquired the WeedPass.com domain, where cannabis consumers can now locate dispensaries participating in the WeedPassTM Rewards Program and earn rewards for their purchases.

Omni Aesthetics is making waves in the medical world of sexual wellness by joining the GAINSWave® movement to offer GAINSWave treatment!

Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that patient dosing has begun in a Phase I clinical study of BAT4306F in relapsed/refractory CD20-positive B-cell non-Hodgkin’s lymphoma patients.

Los Angeles-based organic CBD industry leaders CBDfx have intensely ramped up production of CBD products this week, including popular new Turmeric & Spirulina Gummies, on the heels of what they expect to be explosive demand.

LabCorp® (NYSE: LH), a leading global life sciences company, today announced that its Covance Drug Development (Covance) business was awarded Best Technological Development in Clinical Trials (Clinical Sponsor-Focused) at the 14th Annual Scrip Awards for its Xcellerate® Clinical Research Associate (CRA) Dashboard.